首页> 外文会议>Japanese Cancer Association >Allogeneic Hematopoietic Stem Cell Transplantation For Atl

【24h】

Allogeneic Hematopoietic Stem Cell Transplantation For Atl

机译：ATL的同种异体造血干细胞移植

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aggressive type adult T cell leukemia/lymphoma (ATL) has a very poor prognosis. Chemotherapy can induce long-term remission in only a small percentage of patients due to the intrinsic chemoresistant nature of the disease and to its associated immunodeficiency-

机译：侵略性型成人T细胞白血病/淋巴瘤（ATL）预后非常差。由于疾病的内在化学化学性质和相关免疫缺陷，化疗可以仅诱导少量患者的长期缓解。

著录项

来源
《Japanese Cancer Association》|2003年||共8页
会议地点
作者
Mari Kannnagi; Masao Matsuoka; Takashi Uchiyama; Takayuki Ishikawa; Tatsuo Ichinohe; Kazunori Imadaauthor_name/; Kazuo Suganuma; Kyoto University Kawaracbo; Shogoin; Sakyo-ku; Kyoto -; Japan;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类急性白血病;
关键词

相似文献

外文文献
中文文献
专利

1. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1–associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation [J] . Noriaki Kawano, Shuro Yoshida, Sayaka Kawano, Journal of clinical and experimental hematopathology : . 2018,第3期

机译：同种异体造血干细胞移植后，人类1型T淋巴细胞营养病毒（HTLV-1）感染对成人T细胞白血病-淋巴瘤（ATL）或HTLV-1相关性骨髓病（HAM）/非典型HAM的发展的临床影响（allo-HSCT）和肾移植
2. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience. [J] . Fukushima T, Taguchi J, Moriuchi Y, International journal of hematology . 2011,第4期

机译：涉及中枢神经系统的ATL同种异体造血干细胞移植：长崎移植小组的经验。
3. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: The Nagasaki Transplant Group experience [J] . Takuya Fukushima, Jun Taguchi, Yukiyoshi Moriuchi, International Journal of Hematology . 2011,第4期

机译：涉及中枢神经系统的ATL同种异体造血干细胞移植：长崎移植小组的经验
4. Allogeneic Hematopoietic Stem Cell Transplantation For Atl [C] . Mari Kannnagi, Masao Matsuoka, Takashi Uchiyama, Japanese Cancer Association . 2003

机译：ATL的同种异体造血干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infectionon the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1–associated myelopathy(HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT)and renal transplantation [O] . Noriaki Kawano, Shuro Yoshida, Sayaka Kawano, 2018

机译：人类T型淋巴病毒1型（HTLV-1）感染的临床影响对成人T细胞白血病淋巴瘤（ATL）或HTLV-1相关性脊髓病的发展（HAM）/同种异体造血干细胞移植后的非典型HAM（allo-HSCT）和肾移植
7. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation [O] . Porter David L., Alyea Edwin P., Antin Joseph H., 2010

机译：NCI首届国际同种异体造血干细胞移植后复发的生物学，预防和治疗研讨会：同种异体造血干细胞移植后复发治疗委员会的报告

Allogeneic Hematopoietic Stem Cell Transplantation For Atl

摘要

著录项

相似文献

相关主题

期刊订阅